QTRX250117P27500
- 0.00
- 0.000.00%
Quanterix Newsroom
Leerink Partners Maintains Quanterix(QTRX.US) With Buy Rating
Leerink Partners Sticks to Its Buy Rating for Quanterix (QTRX)
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday
Quanterix Stock Drops 7% on Deal to Buy Emission
Quanterix Will Use Cash on Hand to Acquire EMISSION for $10M, With Additional $10M Payable Upon Completion of Certain Technical Milestones >QTRX
Quanterix Expects the Transaction Will Close in Jan >QTRX
Express News | Quanterix Corp - Transaction Expected to Be Accretive to Revenue and Gross Margins in 2026
Express News | Quanterix Corp - Emission May Receive up to $50 Million in Earnout Payments
Press Release: Quanterix Expands Capabilities With Strategic Acquisition of EMISSION
Express News | Quanterix Expands Capabilities With Strategic Acquisition of Emission
Quanterix Expands Capabilities With Strategic Acquisition of EMISSION
Quanterix Faces Nasdaq Compliance Challenge, Aims for Transparency
Quanterix Announces Receipt of Expected Notice From Nasdaq
Wolf Haldenstein Adler Freeman & Herz LLP Announces That It Is Investigating Quanterix Corporation for Potential Violations of Securities Laws
Express News | Quanterix Corporation Is Now Under Investigation by Johnson Fistel, Llp on Behalf of Shareholders Who Incurred Losses on Their Investments
Quanterix: Strong Growth in Accelerator Services and Strategic Expansion Drive Buy Rating
Express News | Quanterix Corp -Files for Non Timely 10-Q With U.S. SEC
Quanterix Analyst Ratings
Quanterix Shares Are Trading Lower. The Company Reported Q3 Financial Results.
TD Cowen Maintains Quanterix(QTRX.US) With Hold Rating, Maintains Target Price $16